What is the main purpose of this 8-K filing?

This 8-K filing primarily serves to inform investors that the underwriters have fully exercised their option to purchase an additional 3,000,000 ordinary shares from Credo Technology Group Holding Ltd. This is a common occurrence following an IPO and relates to the overallotment option granted to underwriters.

How does the exercise of the underwriter's option affect the IPO?

The exercise of the option means more shares were sold in total during the IPO than initially planned (beyond the base offering). This increases the total number of shares outstanding and the capital raised by the company and selling shareholders. It can also dilute existing shareholders' ownership percentages to a greater extent than the base offering alone.

What does the exercise of the option indicate about investor demand?

The full exercise of the underwriter's option generally indicates strong demand for the company's shares in the market following the IPO. Underwriters typically only exercise these options if they can successfully place the additional shares with investors at or above the IPO price, suggesting positive market reception for Credo Technology.

What was the total number of shares sold in the IPO after the option exercise?

The initial IPO included 18,383,800 shares sold by the company and 1,616,200 shares sold by existing shareholders. With the full exercise of the 3,000,000 share option, the total number of shares sold in the IPO amounts to 22,900,000 (18,383,800 + 1,616,200 + 3,000,000).

CRDO 8-K SEC Disclosure

Summary

This 8-K filing from Credo Technology Group Holding Ltd (CRDO) details the full exercise of the underwriter's option to purchase additional shares following their Initial Public Offering (IPO). The IPO, which priced on January 31, 2022, initially saw the company sell 18,383,800 ordinary shares and certain existing shareholders sell 1,616,200 shares at $10.00 per share. The underwriters' 30-day option to purchase an additional 3,000,000 shares from the company has now been fully exercised, with the purchase closing on February 10, 2022. This exercise of the over-allotment option indicates strong demand and investor confidence in Credo Technology following its public debut. For investors, this means that the total number of shares sold in the IPO, including the overallotment, will be higher than initially planned, potentially impacting ownership dilution and overall market capitalization. The filing confirms the completion of this secondary transaction related to the IPO, providing clarity on the final share count and proceeds.

Key Highlights

1Credo Technology Group Holding Ltd (CRDO) filed an 8-K on February 10, 2022.
2The filing confirms the full exercise of the underwriters' option to purchase an additional 3,000,000 ordinary shares.
3This option was granted in connection with the Company's Initial Public Offering (IPO).
4The purchase of these additional shares closed on February 10, 2022.
5The IPO initially involved the sale of 18,383,800 shares by the Company and 1,616,200 shares by existing shareholders.
6The public offering price for all shares was $10.00 per share.
7The exercise of the full option signifies strong investor demand and confidence post-IPO.

Credo Technology Group Holding Ltd 8-K Report, Corporate Update (Feb 10, 2022)

Summary

Key Highlights

Frequently Asked Questions